Department of Neurosurgery, Critical Care Unit, Capital Medical University Xuanwu Hospital, Beijing, China.
Department of Neurosurgery, Critical Care Unit, Capital Medical University Xuanwu Hospital, Beijing, China.
World Neurosurg. 2024 Jan;181:e867-e874. doi: 10.1016/j.wneu.2023.11.003. Epub 2023 Nov 4.
Patients with cerebral venous sinus thrombosis (CVST) may die during the acute phase due to increased intracranial pressure and cerebral herniation. The purpose of this study was to assess the role of decompressive craniectomy in the treatment of patients with malignant CVST.
Patients who underwent decompressive craniectomy and were consequently admitted to the Critical Care Unit, Department of Neurosurgery, at Capital Medical University Xuanwu Hospital from March 2010 to January 2021 were retrospectively examined with follow-up data at 12 months.
In total, 14 cases were reviewed, including 9 female and 5 male patients, aged 23-63 years (42.7 ± 12.3 years). Prior to surgery, all patients had a GCS score <9. 6 patients had a unilateral dilated pupil, while 4 patients had bilateral dilated pupils. According to the head computed tomography (CT), all patients had hemorrhagic infarction, and the median midline shift was 9.5 mm before surgery. Thirteen patients underwent unilateral decompressive craniectomy, and 1 patient underwent bilateral decompressive craniectomy, among whom, 9 patients underwent hematoma evacuation. Within 3 weeks of surgery, 3 cases (21.43%) resulted in death, with 2 patients dying from progressive intracranial hypertension and 1 from acute respiratory distress syndrome (ARDS). Eleven patients (78.57%) survived after surgery, of whom 4 (28.57%) patients recovered without disability at 12-month follow-up (mRS 0-1), 2 (14.29%) patients had moderate disability (mRS 2-3), and 5 (35.71%) patients had severe disability (mRS 4-5).
Emergent decompressive craniectomy may provide a chance for survival and enable patients with malignant CVST to achieve an acceptable quality of life (QOL).
由于颅内压升高和脑疝,脑静脉窦血栓形成(CVST)患者可能在急性期死亡。本研究旨在评估去骨瓣减压术在治疗恶性 CVST 患者中的作用。
回顾性分析 2010 年 3 月至 2021 年 1 月首都医科大学宣武医院神经外科重症监护病房行去骨瓣减压术并获得 12 个月随访的患者资料。
共纳入 14 例患者,其中女性 9 例,男性 5 例,年龄 23-63 岁(42.7±12.3 岁)。术前所有患者 GCS 评分均<9。6 例患者单侧瞳孔散大,4 例患者双侧瞳孔散大。根据头部 CT,所有患者均有出血性梗死,术前中线移位中位数为 9.5mm。13 例行单侧去骨瓣减压术,1 例行双侧去骨瓣减压术,其中 9 例行血肿清除术。术后 3 周内死亡 3 例(21.43%),其中 2 例死于进行性颅内高压,1 例死于急性呼吸窘迫综合征(ARDS)。术后 11 例(78.57%)存活,其中 4 例(28.57%)在 12 个月随访时无残疾(mRS 0-1),2 例(14.29%)中度残疾(mRS 2-3),5 例(35.71%)严重残疾(mRS 4-5)。
紧急去骨瓣减压术可为恶性 CVST 患者提供生存机会,并使患者获得可接受的生活质量(QOL)。